A commencing dose of 25 mg should be thought of in people with any diploma of hepatic impairment [see DOSAGE AND ADMINISTRATION and Medical PHARMACOLOGY]. NO then activates the enzyme guanylate cyclase, which ends up in elevated amounts of cyclic guanosine monophosphate (cGMP), developing smooth